Systematic Review of Naturally Derived Substances That Act as Inhibitors of the Nicotine Metabolizing Enzyme Cytochrome P450 2A6
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25158031 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Haralampos Tzoupis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of ChemInformatics, NovaMechanics Ltd., Nicosia 1070, Cyprus. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2A6, Nicotine. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research and Innovation Foundation, EU H2020 project EthnoHERBS.
Abstract (Originalsprache)
Tobacco smoking has been highlighted as a major health challenge in modern societies. Despite not causing death directly, smoking has been associated with several health issues, such as cardiovascular diseases, respiratory disorders, and several cancer types. Moreover, exposure to nicotine during pregnancy has been associated with adverse neurological disorders in babies. Nicotine Replacement Therapy (NRT) is the most common strategy employed for smoking cessation, but despite its widespread use, NRT presents with low success and adherence rates. This is attributed partially to the rate of nicotine metabolism by cytochrome P450 2A6 (CYP2A6) in each individual. Nicotine addiction is correlated with the high rate of its metabolism, and thus, novel strategies need to be implemented in NRT protocols. Naturally derived products are a cost-efficient and rich source for potential inhibitors, with the main advantages being their abundance and ease of isolation. This systematic review aims to summarize the natural products that have been identified as CYP2A6 inhibitors, validated through in vitro and/or in vivo assays, and could be implemented as nicotine metabolism inhibitors. The scope is to present the different compounds and highlight their possible implementation in NRT strategies. Additionally, this information would provide valuable insight regarding CYP2A6 inhibitors, that can be utilized in drug development via the use of in silico methodologies and machine-learning models to identify new potential lead compounds for optimization and implementation in NRT regimes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of ChemInformatics, NovaMechanics Ltd., Nicosia 1070, Cyprus.
- Department of ChemInformatics, NovaMechanics MIKE, 18545 Piraeus, Greece.
- School of Life and Health Sciences, University of Nicosia, Nicosia 1700, Cyprus.
- Division of Physical Sciences and Applications, Hellenic Military Academy, 16672 Vari, Greece.
- Division of Data Driven Innovation, Entelos Institute, Larnaca 6059, Cyprus.
ORCID-Profile: Konstantinos D Papavasileiou, Lefteris C Zacharia, Antreas Afantitis
Förderung
- Research and Innovation Foundation
- EU H2020 project EthnoHERBS
Zitieren
APA
Tzoupis, H., Papavasileiou, K. D., Papatzelos, S., Mavrogiorgis, A., Zacharia, L. C., Melagraki, G., & Afantitis, A. (2024). Systematic Review of Naturally Derived Substances That Act as Inhibitors of the Nicotine Metabolizing Enzyme Cytochrome P450 2A6. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158031
Vancouver
Tzoupis H, Papavasileiou KD, Papatzelos S, Mavrogiorgis A, Zacharia LC, Melagraki G, et al. Systematic Review of Naturally Derived Substances That Act as Inhibitors of the Nicotine Metabolizing Enzyme Cytochrome P450 2A6. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158031
BibTeX
@article{Tzoupis2024,
author = {Tzoupis, Haralampos and Papavasileiou, Konstantinos D and Papatzelos, Stavros and Mavrogiorgis, Angelos and Zacharia, Lefteris C and Melagraki, Georgia and Afantitis, Antreas},
title = {Systematic Review of Naturally Derived Substances That Act as Inhibitors of the Nicotine Metabolizing Enzyme Cytochrome P450 2A6},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25158031}
}
EUVIMED